SCOPUS 정보 검색 플랫폼

Journal of Biological Inorganic Chemistry

Volumn 15, Issue 5, 2010, Pages 737-748

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

(11) Heffeter, Petra a Böck, Katharina b Atil, Bihter a Reza Hoda, Mir Ali a Körner, Wilfried c Bartel, Caroline c Jungwirth, Ute a Keppler, Bernhard K c Micksche, Michael a Berger, Walter a Koellensperger, Gunda b

a MEDICAL UNIVERSITY OF VIENNA (Austria)

b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES (Austria)

c UNIVERSITY OF VIENNA (Austria)

Author keywords

Anticancer; Drug uptake; Intracellular distribution; Ruthenium; Size exclusion chromatography inductively coupled plasma mass spectrometry

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; INDAZOLIUM TETRACHLOROBIS(INDAZOLE)RUTHENATE; KP 1339; PLATINUM DERIVATIVE; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DRUG ACTIVATION; DRUG PROTEIN BINDING; DRUG UPTAKE; ENZYME ACTIVATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; MASS SPECTROMETRY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BINDING SITES; CELL PROLIFERATION; CYTOSOL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDAZOLES; MASS SPECTROMETRY; MOLECULAR WEIGHT; ORGANOMETALLIC COMPOUNDS; PROTEIN BINDING; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 77953293948 PISSN: 09498257 EISSN: None Source Type: Journal
DOI: 10.1007/s00775-010-0642-1 Document Type: Article

Times cited : (151)

References (36)

1
- 43049147578
- 10.1016/j.cbpa.2007.11.013 1:CAS:528:DC%2BD1cXlslKlsbs%3D 18155674
- PC Bruijnincx PJ Sadler 2008 Curr Opin Chem Biol 12 197 206 10.1016/j.cbpa.2007.11.013 1:CAS:528:DC%2BD1cXlslKlsbs%3D 18155674
- (2008) Curr Opin Chem Biol , vol.12 , pp. 197-206
- Bruijnincx, P.C.¹ Sadler, P.J.²

2
- 42749083620
- 10.1016/j.drup.2008.02.002 1:CAS:528:DC%2BD1cXlslWqtbg%3D 18394950
- P Heffeter U Jungwirth M Jakupec C Hartinger M Galanski L Elbling M Micksche B Keppler W Berger 2008 Drug Resist Updat 11 1 16 10.1016/j.drup.2008. 02.002 1:CAS:528:DC%2BD1cXlslWqtbg%3D 18394950
- (2008) Drug Resist Updat , vol.11 , pp. 1-16
- Heffeter, P.¹ Jungwirth, U.² Jakupec, M.³ Hartinger, C.⁴ Galanski, M.⁵ Elbling, L.⁶ Micksche, M.⁷ Keppler, B.⁸ Berger, W.⁹

3
- 70349381479
- 10.2174/092986709788682083 1:CAS:528:DC%2BD1MXptVahs74%3D 19601785
- G Cossa L Gatti F Zunino P Perego 2009 Curr Med Chem 16 2355 2365 10.2174/092986709788682083 1:CAS:528:DC%2BD1MXptVahs74%3D 19601785
- (2009) Curr Med Chem , vol.16 , pp. 2355-2365
- Cossa, G.¹ Gatti, L.² Zunino, F.³ Perego, P.⁴

4
- 33745384809
- From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
- DOI 10.1016/j.jinorgbio.2006.02.013, PII S0162013406000754
- CG Hartinger S Zorbas-Seifried MA Jakupec B Kynast H Zorbas BK Keppler 2006 J Inorg Biochem 100 891 904 10.1016/j.jinorgbio.2006.02.013 1:CAS:528:DC%2BD28XksVCluro%3D 16603249 (Pubitemid 44308176)
- (2006) Journal of Inorganic Biochemistry , vol.100 , Issue.5-6 , pp. 891-904
- Hartinger, C.G.¹ Zorbas-Seifried, S.² Jakupec, M.A.³ Kynast, B.⁴ Zorbas, H.⁵ Keppler, B.K.⁶

5
- 22844452813
- The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells
- DOI 10.1016/j.canlet.2005.01.002, PII S0304383505000340
- S Kapitza MA Jakupec M Uhl BK Keppler B Marian 2005 Cancer Lett 226 115 121 10.1016/j.canlet.2005.01.002 1:CAS:528:DC%2BD2MXmsVaisbk%3D 16039951 (Pubitemid 41039079)
- (2005) Cancer Letters , vol.226 , Issue.2 , pp. 115-121
- Kapitza, S.¹ Jakupec, M.A.² Uhl, M.³ Keppler, B.K.⁴ Marian, B.⁵

6
- 77953290344
- Kapitza S, Pongratz M, Jakupec MA, Heffeter P, Berger W, Lackinger L, Keppler BK, Marian B (2004) J Cancer Res Clin Oncol 226:115-121
- (2004) J Cancer Res Clin Oncol , vol.226 , pp. 115-121
- Kapitza, S.¹ Pongratz, M.² Jakupec, M.A.³ Heffeter, P.⁴ Berger, W.⁵ Lackinger, L.⁶ Keppler, B.K.⁷ Marian, B.⁸

7
- 77949275871
- Cetinbas N, Webb MI, Dubland JA, Walsby CJ (2010) J Biol Inorg Chem 15:131-145
- (2010) J Biol Inorg Chem , vol.15 , pp. 131-145
- Cetinbas, N.¹ Webb, M.I.² Dubland, J.A.³ Walsby, C.J.⁴

8
- 24644497689
- Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(III) compound with plasma proteins
- DOI 10.1039/b508060f
- M Sulyok S Hann CG Hartinger BK Keppler G Stingeder G Koellensperger 2005 J Anal At Spectrom 20 856 863 10.1039/b508060f 1:CAS:528:DC%2BD2MXpt1aiu7k%3D (Pubitemid 41284843)
- (2005) Journal of Analytical Atomic Spectrometry , vol.20 , Issue.9 , pp. 856-863
- Sulyok, M.¹ Hann, S.² Hartinger, C.G.³ Keppler, B.K.⁴ Stingeder, G.⁵ Koellensperger, G.⁶

9
- 41349120026
- Intracellular iron transport and storage: From molecular mechanisms to health implications
- DOI 10.1089/ars.2007.1893
- EL MacKenzie K Iwasaki Y Tsuji 2008 Antioxid Redox Signal 10 997 1030 10.1089/ars.2007.1893 1:CAS:528:DC%2BD1cXjvFyqurY%3D 18327971 (Pubitemid 351451707)
- (2008) Antioxidants and Redox Signaling , vol.10 , Issue.6 , pp. 997-1030
- Mackenzie, E.L.¹ Iwasaki, K.² Tsuji, Y.³

10
- 19944430023
- Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole) ruthenate (III)] (FFC14A)
- DOI 10.1124/jpet.104.073395
- P Heffeter M Pongratz E Steiner P Chiba MA Jakupec L Elbling B Marian W Korner F Sevelda M Micksche BK Keppler W Berger 2005 J Pharmacol Exp Ther 312 281 289 10.1124/jpet.104.073395 1:CAS:528:DC%2BD2MXhtVWmtbs%3D 15331656 (Pubitemid 40096479)
- (2005) Journal of Pharmacology and Experimental Therapeutics , vol.312 , Issue.1 , pp. 281-289
- Heffeter, P.¹ Pongratz, M.² Steiner, E.³ Chiba, P.⁴ Jakupec, M.A.⁵ Elbling, L.⁶ Marian, B.⁷ Korner, W.⁸ Sevelda, F.⁹ Micksche, M.¹⁰ Keppler, B.K.¹¹ Berger, W.¹²

11
- 0030477371
- Synthesis, characterization and solution chemistry of trans-indazoliumtetrachlorobis(indazole)ruthenate(III), a new anticancer ruthenium complex. IR, UV, NMR, HPLC investigations and antitumor activity
- DOI 10.1155/MBD.1996.243
- KG Lipponer E Vogel BK Keppler 1996 Met Based Drugs 3 243 260 10.1155/MBD.1996.243 1:CAS:528:DyaK2sXnvVyq 18472901 (Pubitemid 27030983)
- (1996) Metal-Based Drugs , vol.3 , Issue.5 , pp. 243-260
- Lipponer, K.-G.¹ Vogel, E.² Keppler, B.K.³

12
- 0032869590
- Peti W, Pieper T, Sommer, Keppler BK, Giester G (1999) Eur J Inorg Chem 1551-1555
- (1999) Eur J Inorg Chem , pp. 1551-1555
- Peti, W.¹ Pieper, T.² Sommer³ Keppler, B.K.⁴ Giester, G.⁵

13
- 30444444231
- Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline) lanthanum(III)]trithiocyanate (KP772; FFC24)
- DOI 10.1016/j.bcp.2005.11.009, PII S0006295205007550
- P Heffeter MA Jakupec W Korner S Wild NG von Keyserlingk L Elbling H Zorbas A Korynevska S Knasmuller H Sutterluty M Micksche BK Keppler W Berger 2006 Biochem Pharmacol 71 426 440 10.1016/j.bcp.2005.11.009 1:CAS:528: DC%2BD28XksVWgtw%3D%3D 16343446 (Pubitemid 43077077)
- (2006) Biochemical Pharmacology , vol.71 , Issue.4 , pp. 426-440
- Heffeter, P.¹ Jakupec, M.A.² Korner, W.³ Wild, S.⁴ Von Keyserlingk, N.G.⁵ Elbling, L.⁶ Zorbas, H.⁷ Korynevska, A.⁸ Knasmuller, S.⁹ Sutterluty, H.¹⁰ Micksche, M.¹¹ Keppler, B.K.¹² Berger, W.¹³

14
- 46349096337
- New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis
- DOI 10.1038/sj.bjc.6604440, PII 6604440
- S Sagmeister M Eisenbauer C Pirker T Mohr K Holzmann H Zwickl C Bichler D Kandioler F Wrba W Mikulits C Gerner M Shehata O Majdic B Streubel W Berger M Micksche K Zatloukal R Schulte-Hermann B Grasl-Kraupp 2008 Br J Cancer 99 151 159 10.1038/sj.bjc.6604440 1:CAS:528:DC%2BD1cXnvFeqsr8%3D 18594539 (Pubitemid 351920238)
- (2008) British Journal of Cancer , vol.99 , Issue.1 , pp. 151-159
- Sagmeister, S.¹ Eisenbauer, M.² Pirker, C.³ Mohr, T.⁴ Holzmann, K.⁵ Zwickl, H.⁶ Bichler, C.⁷ Kandioler, D.⁸ Wrba, F.⁹ Mikulits, W.¹⁰ Gerner, C.¹¹ Shehata, M.¹² Majdic, O.¹³ Streubel, B.¹⁴ Berger, W.¹⁵ Micksche, M.¹⁶ Zatloukal, K.¹⁷ Schulte-Hermann, R.¹⁸ Grasl-Kraupp, B.¹⁹

15
- 51149121476
- 10.1159/000149782 1:CAS:528:DC%2BD1cXhtVKls7bJ 18769031
- V Janson B Andersson P Behnam-Motlagh KG Engstrom R Henriksson K Grankvist 2008 Cell Physiol Biochem 22 45 56 10.1159/000149782 1:CAS:528:DC%2BD1cXhtVKls7bJ 18769031
- (2008) Cell Physiol Biochem , vol.22 , pp. 45-56
- Janson, V.¹ Andersson, B.² Behnam-Motlagh, P.³ Engstrom, K.G.⁴ Henriksson, R.⁵ Grankvist, K.⁶

16
- 0036169078
- 1:CAS:528:DC%2BD38XitVSmtro%3D 11861393
- F Bunz C Fauth MR Speicher A Dutriaux JM Sedivy KW Kinzler B Vogelstein C Lengauer 2002 Cancer Res 62 1129 1133 1:CAS:528:DC%2BD38XitVSmtro%3D 11861393
- (2002) Cancer Res , vol.62 , pp. 1129-1133
- Bunz, F.¹ Fauth, C.² Speicher, M.R.³ Dutriaux, A.⁴ Sedivy, J.M.⁵ Kinzler, K.W.⁶ Vogelstein, B.⁷ Lengauer, C.⁸

17
- 57649208037
- 10.1039/b810481f 1:CAS:528:DC%2BD1cXhsFWisr%2FK
- A Egger C Rappel MA Jakupec CG Hartinger P Heffeter BK Keppler 2009 J Anal At Spectrom 24 51 61 10.1039/b810481f 1:CAS:528:DC%2BD1cXhsFWisr%2FK
- (2009) J Anal at Spectrom , vol.24 , pp. 51-61
- Egger, A.¹ Rappel, C.² Jakupec, M.A.³ Hartinger, C.G.⁴ Heffeter, P.⁵ Keppler, B.K.⁶

18
- 35848955623
- Characterisation of zinc-binding domains of peroxisomal RING finger proteins using size exclusion chromatography/inductively coupled plasma-mass spectrometry
- DOI 10.1515/BC.2007.125
- G Koellensperger S Daubert R Erdmann S Hann HP Rottensteiner 2007 Chem Biol 388 1209 1214 10.1515/BC.2007.125 1:CAS:528:DC%2BD2sXhtlWiurrF (Pubitemid 350059618)
- (2007) Biological Chemistry , vol.388 , Issue.11 , pp. 1209-1214
- Koellensperger, G.¹ Daubert, S.² Erdmann, R.³ Hann, S.⁴ Rottensteiner, H.⁵

19
- 34247616802
- Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
- DOI 10.1016/j.bcp.2007.03.002, PII S0006295207001463
- P Heffeter MA Jakupec W Korner P Chiba C Pirker R Dornetshuber L Elbling H Sutterluty M Micksche BK Keppler W Berger 2007 Biochem Pharmacol 73 1873 1886 10.1016/j.bcp.2007.03.002 1:CAS:528:DC%2BD2sXkvFOjtbs%3D 17445775 (Pubitemid 46677901)
- (2007) Biochemical Pharmacology , vol.73 , Issue.12 , pp. 1873-1886
- Heffeter, P.¹ Jakupec, M.A.² Korner, W.³ Chiba, P.⁴ Pirker, C.⁵ Dornetshuber, R.⁶ Elbling, L.⁷ Sutterluty, H.⁸ Micksche, M.⁹ Keppler, B.K.¹⁰ Berger, W.¹¹

20
- 0033809069
- 10.1002/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO;2-S 1:CAS:528:DC%2BD3cXntlynu7w%3D 11004683
- W Berger L Elbling M Micksche 2000 Int J Cancer 88 293 300 10.1002/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO;2-S 1:CAS:528:DC%2BD3cXntlynu7w%3D 11004683
- (2000) Int J Cancer , vol.88 , pp. 293-300
- Berger, W.¹ Elbling, L.² Micksche, M.³

21
- 36049018701
- Mechanisms underlying the anticancer activities of the angucycline landomycin E
- DOI 10.1016/j.bcp.2007.08.026, PII S0006295207005874
- A Korynevska P Heffeter B Matselyukh L Elbling M Micksche R Stoika W Berger 2007 Biochem Pharmacol 74 1713 1726 10.1016/j.bcp.2007.08.026 1:CAS:528:DC%2BD2sXhtlWrt7jM 17904109 (Pubitemid 350088682)
- (2007) Biochemical Pharmacology , vol.74 , Issue.12 , pp. 1713-1726
- Korynevska, A.¹ Heffeter, P.² Matselyukh, B.³ Elbling, L.⁴ Micksche, M.⁵ Stoika, R.⁶ Berger, W.⁷

22
- 0032610934
- 1:CAS:528:DC%2BD3cXis1Citrw%3D 10500794
- AG Hall 1999 Adv Exp Med Biol 457 199 203 1:CAS:528:DC%2BD3cXis1Citrw%3D 10500794
- (1999) Adv Exp Med Biol , vol.457 , pp. 199-203
- Hall, A.G.¹

23
- 33750450020
- Studying metal integration in native and recombinant copper proteins by hyphenated ICP-DRC-MS and ESI-TOF-MS capabilities and limitations of the complementary techniques
- DOI 10.1039/b604974p
- S Hann C Obinger G Stingeder M Paumann PG Furtmüller G Koellensperger 2006 J Anal At Spectrom 21 1224 1231 10.1039/b604974p 1:CAS:528:DC%2BD28XhtFaksbvM (Pubitemid 44655391)
- (2006) Journal of Analytical Atomic Spectrometry , vol.21 , Issue.11 , pp. 1224-1231
- Hann, S.¹ Obinger, C.² Stingeder, G.³ Paumann, M.⁴ Furtmuller, P.G.⁵ Koellensperger, G.⁶

24
- 69749111264
- 10.1016/j.biochi.2009.03.017 1:CAS:528:DC%2BD1MXhtFantLnM 19344743
- AM Pizarro PJ Sadler 2009 Biochimie 91 1198 1211 10.1016/j.biochi.2009. 03.017 1:CAS:528:DC%2BD1MXhtFantLnM 19344743
- (2009) Biochimie , vol.91 , pp. 1198-1211
- Pizarro, A.M.¹ Sadler, P.J.²

25
- 43649107538
- Direct visualization and quantification of the anticancer agent, cis-diamminedichloro-platinum(II), in human lung cancer cells using in-air microparticle-induced X-ray emission analysis
- DOI 10.1111/j.1349-7006.2008.00755.x
- H Sakurai M Okamoto M Hasegawa T Satoh M Oikawa T Kamiya K Arakawa T Nakano 2008 Cancer Sci 99 901 904 10.1111/j.1349-7006.2008.00755.x 1:CAS:528:DC%2BD1cXlslCrsbg%3D 18294282 (Pubitemid 351997591)
- (2008) Cancer Science , vol.99 , Issue.5 , pp. 901-904
- Sakurai, H.¹ Okamoto, M.² Hasegawa, M.³ Satoh, T.⁴ Oikawa, M.⁵ Kamiya, T.⁶ Arakawa, K.⁷ Nakano, T.⁸

26
- 34047110137
- Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins
- DOI 10.1007/s00280-006-0357-8
- A Pawarode S Shukla H Minderman SM Fricke EM Pinder KL O'Loughlin SV Ambudkar MR Baer 2007 Cancer Chemother Pharmacol 60 179 188 10.1007/s00280-006- 0357-8 1:CAS:528:DC%2BD2sXltFSksbY%3D 17031644 (Pubitemid 46742532)
- (2007) Cancer Chemotherapy and Pharmacology , vol.60 , Issue.2 , pp. 179-188
- Pawarode, A.¹ Shukla, S.² Minderman, H.³ Fricke, S.M.⁴ Pinder, E.M.⁵ O'Loughlin, K.L.⁶ Ambudkar, S.V.⁷ Baer, M.R.⁸

27
- 33747773739
- DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
- DOI 10.1016/j.drup.2006.05.002, PII S1368764606000252
- V Brabec O Novakova 2006 Drug Resist Updat 9 111 122 10.1016/j.drup.2006. 05.002 1:CAS:528:DC%2BD28XoslOgur4%3D 16790363 (Pubitemid 44279519)
- (2006) Drug Resistance Updates , vol.9 , Issue.3 , pp. 111-122
- Brabec, V.¹ Novakova, O.²

28
- 33846440113
- An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells
- DOI 10.1158/0008-5472.CAN-06-1538
- KS Smalley R Contractor NK Haass AN Kulp GE Atilla-Gokcumen DS Williams H Bregman KT Flaherty MS Soengas E Meggers M Herlyn 2007 Cancer Res 67 209 217 10.1158/0008-5472.CAN-06-1538 1:CAS:528:DC%2BD2sXisFSgtQ%3D%3D 17210701 (Pubitemid 46142777)
- (2007) Cancer Research , vol.67 , Issue.1 , pp. 209-217
- Smalley, K.S.M.¹ Contractor, R.² Haass, N.K.³ Kulp, A.N.⁴ Atilla-Gokcumen, G.E.⁵ Williams, D.S.⁶ Bregman, H.⁷ Flaherty, K.T.⁸ Soengas, M.S.⁹ Meggers, E.¹⁰ Herlyn, M.¹¹

29
- 44649150564
- 10.1021/cb800039y 1:CAS:528:DC%2BD1cXlvVynt7o%3D 18484710
- P Xie DS Williams GE Atilla-Gokcumen L Milk M Xiao KS Smalley M Herlyn E Meggers R Marmorstein 2008 ACS Chem Biol 3 305 316 10.1021/cb800039y 1:CAS:528:DC%2BD1cXlvVynt7o%3D 18484710
- (2008) ACS Chem Biol , vol.3 , pp. 305-316
- Xie, P.¹ Williams, D.S.² Atilla-Gokcumen, G.E.³ Milk, L.⁴ Xiao, M.⁵ Smalley, K.S.⁶ Herlyn, M.⁷ Meggers, E.⁸ Marmorstein, R.⁹

30
- 70449359894
- 10.1371/journal.pone.0007112 19841674
- AN Bullock S Russo A Amos N Pagano H Bregman JE Debreczeni WH Lee F von Delft E Meggers S Knapp 2009 PLoS One 4 e7112 10.1371/journal.pone.0007112 19841674
- (2009) PLoS One , vol.4 , pp. 7112
- Bullock, A.N.¹ Russo, S.² Amos, A.³ Pagano, N.⁴ Bregman, H.⁵ Debreczeni, J.E.⁶ Lee, W.H.⁷ Von Delft, F.⁸ Meggers, E.⁹ Knapp, S.¹⁰

31
- 33947425916
- Bergamo A, Sava G (2007) Dalton Trans 1267-1272
- (2007) Dalton Trans , pp. 1267-1272
- Bergamo, A.¹ Sava, G.²

32
- 10844269461
- Ruthenium antimetastatic agents
- DOI 10.2174/1568026043387421
- E Alessio G Mestroni A Bergamo G Sava 2004 Curr Top Med Chem 4 1525 1535 10.2174/1568026043387421 1:CAS:528:DC%2BD2cXhtVKmsbrP 15579094 (Pubitemid 39662663)
- (2004) Current Topics in Medicinal Chemistry , vol.4 , Issue.15 , pp. 1525-1535
- Alessio, E.¹ Mestroni, G.² Bergamo, A.³ Sava, G.⁴

33
- 33645277617
- Schluga P, Hartinger CG, Egger A, Reisner E, Galanski M, Jakupec MA, Keppler BK (2006) Dalton Trans 1796-1802
- (2006) Dalton Trans , pp. 1796-1802
- Schluga, P.¹ Hartinger, C.G.² Egger, A.³ Reisner, E.⁴ Galanski, M.⁵ Jakupec, M.A.⁶ Keppler, B.K.⁷

34
- 56749178706
- 10.1016/j.tox.2008.07.048 1:CAS:528:DC%2BD1cXhsVGhurrP 18694801
- W Bursch A Karwan M Mayer J Dornetshuber U Frohwein R Schulte-Hermann B Fazi F Di Sano L Piredda M Piacentini G Petrovski L Fesus C Gerner 2008 Toxicology 254 147 157 10.1016/j.tox.2008.07.048 1:CAS:528:DC%2BD1cXhsVGhurrP 18694801
- (2008) Toxicology , vol.254 , pp. 147-157
- Bursch, W.¹ Karwan, A.² Mayer, M.³ Dornetshuber, J.⁴ Frohwein, U.⁵ Schulte-Hermann, R.⁶ Fazi, B.⁷ Di Sano, F.⁸ Piredda, L.⁹ Piacentini, M.¹⁰ Petrovski, G.¹¹ Fesus, L.¹² Gerner, C.¹³

35
- 58149350129
- 10.1002/iub.114 1:CAS:528:DC%2BD1cXhsVKgsLnE 18636510
- T Jung T Grune 2008 IUBMB Life 60 743 752 10.1002/iub.114 1:CAS:528:DC%2BD1cXhsVKgsLnE 18636510
- (2008) IUBMB Life , vol.60 , pp. 743-752
- Jung, T.¹ Grune, T.²

36
- 67650456858
- 10.1158/0008-5472.CAN-08-4408 1:CAS:528:DC%2BD1MXnvFajsrY%3D 19549908
- X Meng ML Leyva M Jenny I Gross S Benosman B Fricker S Harlepp P Hebraud A Boos P Wlosik P Bischoff C Sirlin M Pfeffer JP Loeffler C Gaiddon 2009 Cancer Res 69 5458 5466 10.1158/0008-5472.CAN-08-4408 1:CAS:528:DC%2BD1MXnvFajsrY%3D 19549908
- (2009) Cancer Res , vol.69 , pp. 5458-5466
- Meng, X.¹ Leyva, M.L.² Jenny, M.³ Gross, I.⁴ Benosman, S.⁵ Fricker, B.⁶ Harlepp, S.⁷ Hebraud, P.⁸ Boos, A.⁹ Wlosik, P.¹⁰ Bischoff, P.¹¹ Sirlin, C.¹² Pfeffer, M.¹³ Loeffler, J.P.¹⁴ Gaiddon, C.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.